115 related articles for article (PubMed ID: 36734142)
1. Features of T1 pancreatic cancer and validation of the eighth edition AJCC staging system definition using a Korean-Japanese joint cohort and the SEER database.
Kwon W; Heo JS; Han IW; Kang CM; Hwang HK; Kim SC; Park SJ; Yoon YS; Kim YH; Lim CS; Lee SY; Park T; Takami H; Watanabe N; Shimizu Y; Okuno M; Yamaue H; Kawai M; Seiko H; Nagakawa Y; Osakabe H; Sugiura T; Toyama H; Ohtsuka M; Unno M; Endo I; Kitago M; Jang JY
J Hepatobiliary Pancreat Sci; 2023 Sep; 30(9):1129-1140. PubMed ID: 36734142
[TBL] [Abstract][Full Text] [Related]
2. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
Chen HY; Wang X; Zhang H; Liu XB; Tan CL
World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
[TBL] [Abstract][Full Text] [Related]
3. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
Chen YT; Huang ZP; Zhou ZW; He MM
Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
[TBL] [Abstract][Full Text] [Related]
4. Is the New T1 Category as Defined in the Eighth Edition of the AJCC Pancreatic Cancer Staging System an Improvement?
Kwon W; Park T; He J; Higuchi R; Son D; Lee SY; Kim J; Byun Y; Kim H; Kim SW; Wolfgang CL; Yamamoto M; Jang JY
J Gastrointest Surg; 2020 Feb; 24(2):262-269. PubMed ID: 31823321
[TBL] [Abstract][Full Text] [Related]
5. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8
Lee M; Thomas AS; Lee SY; Cho YJ; Jung HS; Yun WG; Han Y; Jang JY; Kluger MD; Kwon W
J Gastrointest Surg; 2023 Nov; 27(11):2484-2492. PubMed ID: 37848688
[TBL] [Abstract][Full Text] [Related]
6. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
[No Abstract] [Full Text] [Related]
7. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
Meng Z; Cao M; Zhang Y; Liu Z; Wu S; Wu H
BMC Gastroenterol; 2019 Apr; 19(1):59. PubMed ID: 31014264
[TBL] [Abstract][Full Text] [Related]
8. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
[TBL] [Abstract][Full Text] [Related]
9. Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).
Kang JS; Mok L; Heo JS; Han IW; Shin SH; Yoon YS; Han HS; Hwang DW; Lee JH; Lee WJ; Park SJ; Park JS; Kim Y; Lee H; Yu YD; Yang JD; Lee SE; Park IY; Jeong CY; Roh Y; Kim SR; Moon JI; Lee SK; Kim HJ; Lee S; Kim H; Kwon W; Lim CS; Jang JY; Park T
Gut Liver; 2021 Nov; 15(6):912-921. PubMed ID: 33941710
[TBL] [Abstract][Full Text] [Related]
10. Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.
Shi S; Hua J; Liang C; Meng Q; Liang D; Xu J; Ni Q; Yu X
Ann Surg; 2019 May; 269(5):944-950. PubMed ID: 29334560
[TBL] [Abstract][Full Text] [Related]
11. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
Li HJ; Chen YT; Yuan SQ
Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
[TBL] [Abstract][Full Text] [Related]
12. Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma.
Liu C; Cheng H; Jin K; Guo M; Lu Y; Wang Z; Yang C; Long J; Ni Q; Yu X; Luo G
Pancreas; 2018 Jul; 47(6):742-747. PubMed ID: 29851752
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system.
Rochefort MM; Ankeny JS; Kadera BE; Donald GW; Isacoff W; Wainberg ZA; Hines OJ; Donahue TR; Reber HA; Tomlinson JS
Ann Surg Oncol; 2013 Dec; 20(13):4322-9. PubMed ID: 23943022
[TBL] [Abstract][Full Text] [Related]
14. Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy - comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society.
Hayasaki A; Mizuno S; Nagata M; Kaluba B; Maeda K; Shinkai T; Ito T; Gyoten K; Fujii T; Iizawa Y; Tanemura A; Murata Y; Kuriyama N; Isaji S; Kishiwada M
HPB (Oxford); 2023 Oct; 25(10):1268-1277. PubMed ID: 37419780
[TBL] [Abstract][Full Text] [Related]
15. Inadequacy of the eighth edition of the American Joint Committee on Cancer pancreatic cancer staging system for invasive carcinoma associated with premalignant lesions in the pancreas: an analysis using the National Cancer Database.
Jung HS; Lee M; Han Y; Thomas AS; Yun WG; Cho YJ; Kluger MD; Jang JY; Kwon W
HPB (Oxford); 2024 Mar; 26(3):400-409. PubMed ID: 38114399
[TBL] [Abstract][Full Text] [Related]
16. Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
Malleo G; Maggino L; Ferrone CR; Marchegiani G; Luchini C; Mino-Kenudson M; Paiella S; Qadan M; Scarpa A; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
Ann Surg Oncol; 2020 Oct; 27(10):3898-3912. PubMed ID: 32307617
[TBL] [Abstract][Full Text] [Related]
17. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
[TBL] [Abstract][Full Text] [Related]
18. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
[TBL] [Abstract][Full Text] [Related]
19. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
[TBL] [Abstract][Full Text] [Related]
20. Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications.
Zhu X; Chen D; Cao Y; Zhao X; Ju X; Shen Y; Cao F; Qing S; Fang F; Jia Z; Zhang H
Cancer Biol Med; 2020 May; 17(2):492-500. PubMed ID: 32587784
[No Abstract] [Full Text] [Related]
[Next] [New Search]
